LeadIQ logo
Learn more at LeadIQ.com

Insights

Drug Development Shionogi Inc. is actively involved in developing innovative medications for various health conditions, including COVID-19, Fragile X syndrome, acute ischemic stroke, metabolic disorders, oncology, hearing loss, malaria, and obstructive sleep apnea. This diverse range of therapeutic areas presents sales opportunities for partnerships and collaborations with healthcare providers and institutions looking for cutting-edge treatment options.

Strategic Partnerships Shionogi Inc. has a strong history of forming strategic partnerships with industry, government agencies, biotech companies, and academia. These collaborations can serve as potential avenues for sales by leveraging existing relationships to introduce and promote new products, expand market reach, and accelerate the adoption of novel therapies.

Regulatory Expertise With the recent hiring of Dr. Ramón Polo as the Senior Vice President, Head of Regulatory Affairs, Shionogi Inc. demonstrates a commitment to ensuring compliance and navigating regulatory processes efficiently. Leveraging this regulatory expertise can facilitate smoother product approvals, enhancing sales opportunities by expediting market entry and access.

Financial Growth Having a revenue range between $100 million to $1 billion signifies financial stability and growth potential. This financial health can instill confidence in prospective partners, investors, and clients, creating a conducive environment for sales negotiations and business development initiatives.

Innovative Pipeline Shionogi Inc.'s robust pipeline of medications targeting unmet medical needs showcases a commitment to innovation. This pipeline represents a wealth of sales opportunities by offering unique solutions to challenging health conditions, attracting interest from healthcare providers seeking advanced treatment options for their patients.

Similar companies to Shionogi Inc. (U.S.)

Shionogi Inc. (U.S.) Tech Stack

Shionogi Inc. (U.S.) uses 8 technology products and services including IBM Cognos Analytics, WordPress, Ceridian, and more. Explore Shionogi Inc. (U.S.)'s tech stack below.

  • IBM Cognos Analytics
    Advanced Analytics And Data Science
  • WordPress
    Content Management System
  • Ceridian
    Enterprise
  • Vue.js
    Javascript Frameworks
  • Cisco
    Network Hardware
  • Perl
    Programming Languages
  • C#
    Programming Languages
  • IIS
    Web Servers

Media & News

Shionogi Inc. (U.S.)'s Email Address Formats

Shionogi Inc. (U.S.) uses at least 1 format(s):
Shionogi Inc. (U.S.) Email FormatsExamplePercentage
First.Last@shionogi.comJohn.Doe@shionogi.com
65%
FLast@shionogi.comJDoe@shionogi.com
33%
FirstLast@shionogi.comJohnDoe@shionogi.com
1%
First.Middle@shionogi.comJohn.Michael@shionogi.com
1%

Frequently Asked Questions

Where is Shionogi Inc. (U.S.)'s headquarters located?

Minus sign iconPlus sign icon
Shionogi Inc. (U.S.)'s main headquarters is located at 300 Campus Drive Florham Park, New Jersey 07932 US. The company has employees across 5 continents, including North AmericaEuropeAsia.

What is Shionogi Inc. (U.S.)'s phone number?

Minus sign iconPlus sign icon
You can contact Shionogi Inc. (U.S.)'s main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Shionogi Inc. (U.S.)'s official website and social media links?

Minus sign iconPlus sign icon
Shionogi Inc. (U.S.)'s official website is shionogi.com and has social profiles on LinkedIn.

How much revenue does Shionogi Inc. (U.S.) generate?

Minus sign iconPlus sign icon
As of September 2024, Shionogi Inc. (U.S.)'s annual revenue reached $750M.

What is Shionogi Inc. (U.S.)'s NAICS code?

Minus sign iconPlus sign icon
Shionogi Inc. (U.S.)'s NAICS code is 3254 - Pharmaceutical and Medicine Manufacturing.

How many employees does Shionogi Inc. (U.S.) have currently?

Minus sign iconPlus sign icon
As of September 2024, Shionogi Inc. (U.S.) has approximately 501 employees across 5 continents, including North AmericaEuropeAsia. Key team members include Chief Medical Officer: T. N.Vice President Marketing: M. M.Vice President Marketing: J. O.. Explore Shionogi Inc. (U.S.)'s employee directory with LeadIQ.

What industry does Shionogi Inc. (U.S.) belong to?

Minus sign iconPlus sign icon
Shionogi Inc. (U.S.) operates in the Pharmaceutical Manufacturing industry.

What technology does Shionogi Inc. (U.S.) use?

Minus sign iconPlus sign icon
Shionogi Inc. (U.S.)'s tech stack includes IBM Cognos AnalyticsWordPressCeridianVue.jsCiscoPerlC#IIS.

What is Shionogi Inc. (U.S.)'s email format?

Minus sign iconPlus sign icon
Shionogi Inc. (U.S.)'s email format typically follows the pattern of . Find more Shionogi Inc. (U.S.) email formats with LeadIQ.

When was Shionogi Inc. (U.S.) founded?

Minus sign iconPlus sign icon
Shionogi Inc. (U.S.) was founded in 2001.
Shionogi Inc. (U.S.)

Shionogi Inc. (U.S.)

Pharmaceutical ManufacturingNew Jersey, United States501-1000 Employees

Since 1878, we have been committed to developing new treatments to improve patients' lives worldwide. We are helping to address global health challenges such as antimicrobial resistance and COVID-19.

Since the 1950s, we have discovered and introduced several novel antibiotics, as well as innovative medications for HIV and influenza. Today, we are developing an investigational oral antiviral for COVID-19 and advancing clinical programs in Fragile X syndrome, acute ischemic stroke as well metabolic disorders and oncology.

Our team is driven to impact patient lives. Our partnerships with industry, government agencies, biotech companies and academia help to advance science with the urgency that today's health challenges demand. Through a combination of in-house discovery and strategic partnerships, we continue to deliver firsts for patients in the U.S. and worldwide.  

Section iconCompany Overview

Headquarters
300 Campus Drive Florham Park, New Jersey 07932 US
Phone number
NAICS Code
3254 - Pharmaceutical and Medicine Manufacturing
Founded
2001
Employees
501-1000

Section iconFunding & Financials

  • $100M$1B

    Shionogi Inc. (U.S.)'s revenue is in the range of $100M$1B

Section iconFunding & Financials

  • $100M$1B

    Shionogi Inc. (U.S.)'s revenue is in the range of $100M$1B

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.